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I. INTRODUCTION
Post  Operative  Nausea  and  Vomiting  (PONV),  despite  the  advance  in  anaesthetic 
care,  is  still  a  ‘big  little  problem’1  within  the  anaesthesia  world.1  It  is  defined  as 
nausea  and/or  vomiting  that  occurs  within  24hrs  after  surgery  and  can  occur  following 
general,  regional  or  local  anaesthesia.  It  is  their  most  distressing  concern  in  post 
operative  period.  The  incidence  can  be  as  high  as  80%  following  certain  procedures 
like  ENT,  Laparoscopic  (or)  gynecological  surgeries.  When  severe,  post  operative  nausea 
and   vomiting   can   lead   to   wound   dehiscence,   bleeding,   dehydration,   electrolyte 
imbalance,  delayed  discharge  and  increased  treatment  cost.
II AIM  OF  STUDY
The  aim  of  this  study  is  to  compare  and  evaluate  the  effect  of  granisetron  and 
combination  of  granisetron  with  Dexamethasone  given  prophylactically  in  the  prevention 
of  post  operative  nausea  and  vomiting  in  patients  undergoing  elective  ENT  surgeries.
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III. PHYSIOLOGY  OF  NAUSEA  AND VOMITING
Nausea  and  vomiting  are  important  defense  mechanisms  against 
the  ingestion  of  toxins.
Nausea: It  is  a  subjective  sensation  of  the  desire  to  vomit,  but 
without  any     attempt  at  expulsive  movements.
Retching:  Is   the   spasmodic,   rhythmic   contractions   of   the 
respiratory  muscles  including  the  diaphragm,  chest  wall  and  abdominal 
muscles  with out  actual  expulsion  of  gastric  contents.
Vomiting  is  the  forceful  expulsion  of  gastric  contents  by  strong 
&  sustained  contractions  of  Abdominal  muscles.
Mediators  Of  Vomiting  Reflex:
Vomiting  is  initiated  by  an  afferent  pathway  stimulus  either  from 
viscera  (or)  from  certain  areas  of  brain.  These  impulses  are  transmitted 
by  afferent  fibers  of  both  the  sympathetic  and  para  sympathetic  system 
to  the  specialized  centers  in  brain,  where by  an  emetic  response  is 
initiated.  
AFFERENT  PATHWAY
1.  Chemoreceptor  Trigger  Zone  (CTZ)  :
The  CTZ  is  located  in  the  area  postrema  on  the  floor  of  IV 
ventricle  near  the  vomiting  centre.  These  area  is  lack  of  blood  brain 
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barrier  and  hence  responds  to  circulating  drugs  like  Opoids,  Cytotoxic 
drugs,  Cardiac Glycosides,   Emetine,  transmitters  like  Dopamine  (D2) 
5HT  (5HT3  )  Histamine  hormones.
2.  Higher  Cortical  Centre:
Various  Psychic  stimuli  like  bad  odours,  unpleasant  sight,  pain 
and  fear  through  various  pathway  centers  stimulate  the  vomiting  centre.
3.  Vestibular  apparatus:
It  sends  signal  to  the  vomiting  centre  through  vestibular  portion 
of  VIII  cranial  nerve  when  it  is  stimulated  either  by  body  movement  or 
by  ototoxic  drugs.
4.  Visceral  Receptors
a.  Mechano  receptors:
Found   in   the   muscle   layer   of   GIT.   They   are 
stimulated  by distension,  contraction  of  GIT  or  by  physical 
damage  (Surgical  stimulus)
b. Chemo  receptors:
They  are  located  in  the  upper  GI  and  respond  to 
irritant  which  release  5HT  from  ECF  cells.  Both  these 
receptors  send  signals  through  the  vagus  and  sympathetic 
afferents  via  the  spinal  cord.
  5.  Glossopharyngeal  stimulation  is  by  stimulating  the  back  of  the 
throat, sends  signal  to  vomiting  centre.
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6.  Afferents  from  renal  pelvis,  peritoneum  and  genitalia  are  relayed 
by  ANS  afferent  neurons  to  vomiting  centre.
CENTRAL  INTEGRATIVE  MECHANISM:  
Vomiting  centre  is  an  ill  defined  area  located  in  the  paracellular 
area  of  the  lateral  reticular  formation  of  medulla  in  close  proximity  to 
the  nucleus  of  tractus  solitarius  and  area  postrema  at  the  level  of  dorsal 
motor  nucleus  of  the  vagus  nerve.  Vomiting  occurs  due  to  stimulation 
of  vomiting  centre.
EFFERENT  PATHWAY:
The  motor  impulses  that  cause  actual  vomiting  are  transmitted 
from  vomiting  centre  through  5th,  7th,  9th,  10th  and  12th  cranial  nerve  to 
the  upper  GIT  and  through  the  spinal  nerves  to  the  diaphragm  and 
abdominal  muscles.  
The  act  of  emesis  involves  a  sequence  of  events  that  can  be 
divide  into  (i)  pre  ejection.  (ii)  ejection  and  (iii)  post  ejection  phases.
  The  pre   ejection  phase   comprises   pro  dromal   symptoms  of 
nausea,  along  with  autonomic  signs  such  as  salivation,  sweating,  pallor 
and  tachycardia.  The ejection  phase  consist  of  vomiting  and  retching. 
The  post  ejection  phase  consist  of  autonomic  and  visceral  responses 
that  return  the  body  to  a  quiescent  phase  with  or  without  residual 
nausea.
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AETIOLOGY  OF  POST  OPERATIVE  NAUSEA  AND 
VOMITING
I. Non  Anaesthetic  Factors
 Patient  related  factors
 Surgical  factors
II  Anaesthesia  Related  Factors
 Pre  medication
 Gastric  distension  and  suction
 Anaesthetic  techniques  and  agents
 Post  operative  factors
Patient  Related  Factors
1.  Age:  Incidence  in  children  increases  after  3  yrs  with  a 
peak  in  11  –  14  years  age  group  and  decreases  in  the 
elderly.2
2. Gender:  Female  patients  have  a  2  to  3  times  greater 
incidence  of  post  operative  nausea  and  vomiting  especially 
in  ovulatory  and  luteal  phase .3,4
3. History  of  motion  sickness  also  increases  the  incidence  due 
to  lower  threshold  and  a  well  developed  reflex  arc  for 
vomiting.
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4. Obesity:  There  is  a  positive  correlation  between  body  wt. 
and  post  operative  nausea  and  vomiting  and  is  due  to  the 
fact  that  adipose  tissue  acts  as  a  reservoir  for  inhaled 
anesthetic   agents   and     they   are   more    prone   for 
oesophageal  reflux  disease.2,5
5. Pre  operative  anxiety:  It  has  been  suggested  that  increased 
levels  of  catecholamines  may  be  a  contributing  factor, 
excessive  air  swallowing  seen  in  anxious  patients,  cause 
gastric  distension  resulting  in  vomiting.
Surgical  factors
(i) Type  of  Surgery:
High  incidence  have  been  reported  in  Laparoscopic, 
Gynecological,   breast   surgeries,   gallbladder,  ENT,  and 
Strabismus  surgeries. Post  operative  nausea  and  vomiting 
after  middle ear  surgery  increases  upto  80%.6
(ii) Duration  of  surgery:
Longer   durations   allow  longer   exposure   to   lipid 
soluble,   potentially   emetic   Intravenous/Inhalational 
anesthetics.  This  can  trigger  vomiting  in the post  operative. 
period.
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ANAESTHESIA  RELATED  FACTORS
(i) Pre  medication  
Pre medication  with  opioids  increase   the   incidence,   by 
stimulating  opioid  receptors. Opoids  pre  dispose  to  post  operative 
nausea  and  vomiting  by  sensitizing  the  otic  and  vestibular  areas 
to  motion  They prolong  gastric   emptying  time  by  decreasing 
gastric  and  GI  motility,  .  However  if  opioids  are  not  given  it 
still  causes  vomiting  due  to  increased  pain. 2,7
Benzodiazepam  decreases  the  incidence  of  post  operative 
nausea   and   vomiting   by   decreasing   the   plasma   level   of 
catecholamines.  Atropine  cause  relaxation  of  the  sphincter  and 
delays  gastric  emptying.8
(ii) Gastric  distension  and  suctioning:
Gastric  suctioning  may  reduce  post  operative  nausea  and 
vomiting  following  difficult  and  vigorous  mask  ventilation,  but 
the   continued  presence  of  NG  tube,  may  stimulate  the  gag 
reflex.2,7
(iii)Anaesthetic  Techniques  And  Agents
(a)Spinal   anaesthesia   is   generally   associated   with   less 
emesis  than  General Anaesthasia.  Cephalad  migration  of  opioids 
stimulate  area  postrema.  This  is  common  with  less  lipid  soluble 
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agents  like  morphine.  High  blockade  due  to  un  opposed  vagal 
tone  increases  GI  peristalsis  and  cause  vomiting
(b) Volatile  Anaesthetics:
Due  to  sympathetic  stimulation  of  older  anaesthetic  agents  like 
ether,  choloroform,  and  cyclopropane  the  incidence  was  higher  than 
more  recently  introduced  fluorinated  anaesthetics. However  newer agents 
also  causes  early  post  operative  nausea  and  vomiting10
N2O  can  cause  post   operative  nausea  and  vomiting  with  a 
incidence  ranging  from  49-67% . It  contributes  through  the  following7  
 Diffusion  of  N2O  into  the  middle  ear  increases  its  pressure 
and  consequent  stimulation  of  vestibular  system.
 Gaseous  distension  of  the  bowel.
 Sympathetic  stimulation.
However  in  one  study  by  Muir et al  found  that  there  is  no  association 
between  N2O  and  development  of  post  operative  nausea  and  vomiting.
(c) Intravenous   Anaesthetics
Ketamine  and  etomidate  based  anaesthesia  cause  more  post 
operative   nausea   and   vomiting   than   thiopentone   and 
methohexitone.  The  emetic  effects  of  ketamine  may  be  due  to 
release  of  endogenous  catecholamines . 2
Propofol  and  midazolam  have  been  shown  to  be  associated 
with  less  post  operative  nausea  and  vomiting.
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Neostigmine  used  for  reversal  of  muscle  relaxation  may 
increases  post  operative  nausea  and  vomiting  due  to  increased  gut 
motility.9
(d)  Postoperative  Factors
(i)  Pain: Visceral/Pelvic  pain  can  cause  post  operative  nausea 
and  vomiting.
(ii)  Ambulation:
Sudden  movements,  changing  in  posture  can  precipitate 
vomiting  in  patients  receiving   opioids.
(iii) Postural  hypotension  in  post  operative  period  can  increase 
the  incidence  of  post  operative  nausea  and  vomiting.
(iv) Opioids:  
Nausea  and  Vomiting  are  common  side  effects  of  opioids 
administered  during  post  operative  period.
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COMPLICATIONS  OF  POST  OPERATIVE  NAUSEA 
AND  VOMITING
Patient  related:
Post  operative  nausea  and  vomiting  causes  delay  in  ingestion  of 
fluids,   foods,   oral   medication  and   causes   accompanying  pain   and 
discomfort.2,7
Medical:
 post  operative  nausea  and  vomiting  cause  interruption  of  diet, 
nutrition,  oral  drug  therapy,  aspiration  of  gastric  contents  electrolyte 
imbalance,  dehydration,  Tachycardia,  cardiac  dysrrythmyias,   increased 
intracranial tension,  intraocular  pressure  and    bloodpressure.2,7
Surgical:
  Surgical   complications   include   visceral   wound   dehiscence, 
bleeding   at   the   surgical  site,   disruption   of   vascular   grafts   and 
anastamoses,  and  oesophageal  rupture  (or)  tears.
Cost:
  post   operative  nausea  and  vomiting  cause   increased  stay  in 
Hospital  and  cost  and  delay  in  returning  to  work.
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Apfel  et  al  concluded  a  prediction  that  female  sex,  history  of 
motion  sickness  /  post  operative  nausea  and  vomiting,  non  smoking 
status,  use  of  post  operative  opioids  were  associated  with  increased 
incidence  of  post  operative  nausea  and  vomiting 11.  The  incidence  of 
post  operative  nausea  and  vomiting  with  0,1,2,3,  or  all  4  of  these  risk 
factors  were  10%,  21%,  39%,  61%  and  79%  respectively.
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PERIOPERATIVE  MANAGEMENT  OF  POST 
OPERATIVE  NAUSEA  AND  VOMITING
  Through  pre  operative  assessment  of  patient  if  two  or  more  risk 
factors  are  present,  then  appropriate  modification  may  be  made  in  the 
plan  of  anaesthesia  such  as  avoidance  of   emetic  agents  (or)  by  giving 
prophylactic  anti  emetic  therapy.
 In  addition  to  prophylactic  anti  emetic  therapy  other  measures  to 
decrease  the  incidence  of  post  operative  nausea  and  vomiting include:12, 
13 
  Minimizing  gastric  volume  and  distension  by  fasting, 
  Addition  of H2  receptor  antagonist,
 Prokinetic  agents, 
  non  particulate  antacids  to  reduce  PH, 
  Administration  of  anxiolytic  agents like  midazolam,
   Avoidence  of  drugs like  atropine  that  decrease  sphincter  tone , 
 Use  of  intravenous  anaesthestics  like  propofol,
 Prevention  of  excessive  stomach  distension  with  mask  ventilation 
by  gastric  suctioning,
   Maintenance  of  adequate  fluid  status  intra  operatively,
 Prevention  of  hypoxia,  hypercarbia  and  hypotension ,
 Use  of  regional  blockade  whenever  possible ,
 Minimize  the  usage  of  opioid  analegic  through  use  of  NSAIDS 
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and  local  infiltration,
 Avoidence  of  early  and  excessive  movement,
 Prompt  removal  of  oral/   nasal  tubes  will   all   decrease  post 
operative  nausea  and  vomiting  .
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ANTI  EMETIC  THERAPY
1.  Pharmacological Therapy
2.  Non   Pharmacological Therapy
3.  Adjuvant Therapy
1.  Pharmacological Therapy
Many   of   the   concepts   of   anti   emetic   therapy   in   surgical 
populations  have  been  adopted  from  successful   treatment   protocols 
utilized  in  oncology  in  relation  to  chemotherapy  induce  emeses.  
Four  major  neurotransmitter  systems  appear  to  mediate  the  emetic 
response.
Dopaminergic  (D2)  histaminic  (H1)  cholinergic  muscarinic  and 
serotonergic.
Based  upon  the  receptor  sites  traditional  anti  emetics  that  block  the 
different  neurotransmitter  receptors  are  used.
The  ideal  anti  emetic  drug  should  be  effective  in  preventing  and 
treating  nausea  and  vomiting  with  minimal  side  effects,  it  should  be 
easy  to  administer  and  it  should  be  long  acting.  In  this  regard  no 
single   anti   emetic   drug   is   100%  effective   due   to   multifactorial 
stimulation  for  post  operative  nausea  and  vomiting  and  so  a  multi 
model  approach  is  the  best  approach.
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Anticholinergics:
They  probably  act  by  blocking  conduction  of  nerve  impulse 
across  a  cholinergic  link  through  Muscarinic  M3  and  M5  receptors. 
(e.g)  Hyoscine  (0.2  -  0.4  mg  oral,  Im)  and  dicyclomine  (10  - 
20mg  oral)
 uses:  for  the  prophylaxis  of  motion  sickness.  
 Main  side  effects   are  dry   Mouth,   sedation,   blurred  vision, 
memory  loss,  confusion  and  urinary  retention.
Anti  Histamines:
They  act  on  the  vomiting  center,  vestibular  pathways  with  little 
action  at  the  CTZ.  They  block  acetyl  choline  receptors  in  vestibular 
apparatus  and  H1  receptors  in  the  nucleus  of  solitary  tract
Uses:Prophylaxis  and  therapy  of  vertigo,  motion  sickness  and  in 
control  of  emesis  following  middle  ear  surgery.  They  block  the  extra 
pyramidal  side  effects  of  metoclopramide.
(e.g):  Promethazine  Diphenhydramine,  Dimenhydramine
Main  side  effect  is  excessive  sedation.
  
Neuroleptics  (Butyrophenones):
They  are  potent  anti  emetics,  act  by  blocking  D2  receptor  in 
CTZ  and  area  postrema.   They  are  more  effective  when  given  at  the 
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end  of  surgery  than  at  induction.  Not  effective  in  motion  sickness 
because  the  vestibular  pathway  dose not  involve  dopaminergic  link.
(e.g)  Proclorperazine,  Chlorpromazine.
Side  effects:  Drowsiness, extra  pyramidal  reactions.
Prokinetic  drugs:
(a) Benzamides:
It  is  chemically  related  to  procainamide  and  has  both  central  and 
peripheral  antiemetic  actions.  It  acts  through  both  dopaminergic  and 
serotonergic  pathways.
It  blocks  D2  receptors  and  enhances  acetylcholine  release  in  GIT 
promoting  gastric  emptying  and  increases lower oesophageal  tone.  Central 
D2  antagonism  on  CTZ  is  also  responsible  for  its  anti  emetic  activity.
Because  of  its  short  duration  of  action  it  is  not  administered  before 
induction.
Side  Effects:
Sedation,   dizziness,   muscle   dystonias.   Long-term  use   causes 
parkinsonism  and  galactorrhoea.
( b ) Domperidone:
It  is  a  D2  Antagonist,  chemically  related  to  haloperidol.  Blocks 
D2  receptors  in  upper  GI.  It  crosses  BBB  poorly,  so  extra  pyramidal 
side  effects  are  rare.  Well  absorbed  orally.  Bio  availability  is  only 
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15%.
Side  Effects:
Dry  mouth,  loose  stools,  head ache,  galactorrhoea.
(c) Phenothiazines:
They  are  widely  used  as  anti  emetics  world  wide.  They  exert  a 
direct  dopamine  (D2)  receptor  blocking  effects  on  CTZ  with  moderate 
antihistaminic  and  anticholinergic  actions.
They   have   an   aliphatic   (less   anti   emetic   and   less   extra 
pyramidal)  and  heterocyclic  (more  extra  pyramidal)  ring  compounds.
Neuroleptic  malignant  syndrome,  dry  mouth,  urinary  retention 
tachycardia  are  the  main  drawbacks  of  these  drugs.
Other  Adjuvants:
(I) Benzodiazepines:
They  have  weak  anti  emetic  property  based  mainly  on  sedation. 
They  alleviate  the  anxiety  and  there  by  decrease   catecholamine  levels 
and   producing  amnesia  for  the  unpleasant  procedures  and  hence  reduce 
post  operative  nausea  and  vomiting.
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(II) Clonidine:
The   antiemetic   effects   of   clonidine   is   multifactorial.   They 
significantly   reduce   the   volatile   anaesthetic   requirement,   a   general 
reduction  in  sympathetic  out  flow  and  the  analgesic  effect.  All  reducing 
the  incidence  of  post  operative  nausea  and  vomiting 21
(III) Ephedrine:
It   is   an  indirectly   acting  sympathomimetic  drug,   which  can 
prevent   motion   sickness   and   post   operative   nausea   and   vomiting 
secondary  to  fluid  dehydration  and  orthostatic  hypotension.14    
(IV) Neurokinin  Antagonists:
They  are  effective  in  the  prevention  of  post  operative  nausea  and 
vomiting  because  of  their  ability  to  block  input  from  emetic  stimuli  in 
CNS.  They  act  synergistically  with  5HT3  antagonists.
Non  Pharmacological  Therapy:
Compared   to   placebo,   acupuncture   use   in   various   forms 
effectively  reduces  post  operative  nausea  and  vomiting.
Most   studies   use   P6   (nei-guan)   Pericardium   point.   It   is 
recommended  that  stimulation  be  initiated  before  induction.15
26
DEXAMETHASONE
In  1980,  Rich  at  al  demonstrated  the  effectiveness  of  methyl 
prednisolone   in   controlling   nausea   and   vomiting   following   cancer 
chemotherapy.16  Later  Dexamethasone  was  also  reported  as  a  useful  anti 
emetic  in  chemotherapy  induced  nausea  and  vomiting17
Various   randomized   controlled   study   have   shown   that 
dexamethasone  and  other  agents  were  effective  in  preventing  nausea  and 
vomiting.
 .
Mechanism  of  action :
  The  exact   mechanism  of  dexamethasone  induced  anti   emetic 
activity  is  not  fully  understood.  It  may  involve  two   theories:
(1)  Central  inhibition  of  prostaglandin  synthesis  and    release  of 
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endorphins,  resulting  in  mood  elevation,  a  sense  of  well  being  and 
appetite  stimulation.  
(2)   By   depleting   its   precursor   tryptophan.19  They   regulate 
neurotransmitter  concentrations,   receptor  densities,   signal   transduction 
and  neuronal  configuration. 18     
  Numerous  glucocorticoid  receptors  are  found  in  the  nucleus  of 
tractus  solitarius,  the  raphe  nucleus  and  area  postrema. 
 Dexamethasone  may  have  anti  vertigo  effect  due  to  the  anti 
inflammatory  action,  reducing  the  transient  vestibulitis  following  surgical 
insult.
Dosage :   8 -20 mg  intravenous
The   plasma   elimination   half   life   of   dexamethasone   is 
approximately  4  to  4.5hrs  and  its  duration  of  action  is  36  to  72  hr.18
Side effects:
The  most  commonly  reported  adverse  effects  are  flushing  and 
perineal  itching20
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SEROTONIN   ANTAGONISTS
Serotonin  (or)  5-hydroxytryptamine,  is  a  biogenic  alkylamine  synthesized 
from  tryptophan.  90%  of  serotonin  is  located  peripherally  in  the  entero 
chromaffin  cells  of  intestinal  mucosa  and  10%  is  found  in  CNS. 
 Serotonin  receptors  are  found  peripherally  in  the  vagus  nerve 
terminals  and  centrally  within  the  limbic  system,  cerebral  cortex  and 
the  chemoreceptor  trigger  zone.
  Serotonin   receptors   have   been   categorized   into   five   main 
subclasses.  The  majority  of  the  receptors  are  G-protein-coupled  receptors 
with  the  exception  of  5HT3  receptor,  which  are  ligand  gated  or  fast  ion 
channel.
  All  receptors  are  involved  in  physiologic  functional  response 
with  the  5HT3  receptor  being  involved  in  the  process  of  vomiting.  The 
5HT3  receptor  was  identified  specifically  as  a  target  for  anti  emetics 
when  fozard  observed  that  metoclopramide  had  weak  5HT3  antagonistic 
properties.
  The  5HT3  receptor  antagonists  are  potent  and  highly  selective 
competitive  inhibitors  of  the  5HT3  receptor  with  a  selectivity  ratio  of 
100:1  for  the  5HT3  receptor  as  compared  to  the  other  5HT  receptor.
The  anti   emetic   action  of   the   5HT3  antagonists   is   due  to 
simultaneous  effects  at  both  central  and  peripheral  5HT3  receptor  sites.
  5HT3  receptor  antagonists  are  rapidly  absorbed  and  cross  the 
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blood  brain  barrier,  their  elimination  half  life  varies  from  3 – 4  hrs  for 
ondansetron  and  granisetron  to  7 – 10  hrs.  for  Dolasetron.  Overall  the 
duration  of  anti  emetic  effect  appears  to  be  longer  than  what  would  be 
expected  due  to  their  increased  affinity  for  the  5HT3  receptor  site22
  
They  are  metabolized  via  various  subtypes  of  cytochrome  P–450 
system  in  the  liver  and  the  resulting  metabolites  are  excreted  mainly  in 
the  urine.
By  selectively  working  at  the  5HT3  receptors,  5HT3  antagonists 
avoid  the  adverse  effects  of  some  of  the  traditional  anti  emetics.  
They  are  tolerated  over  a  wide  dose  range,  most  common  side  effects 
are  headache  and  constipation
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GRANISETRON
It  is  an  Indazole  derivative  
It  is  a  5HT3  –  receptor  antagonist,  which  is  10-15  times  more  potent 
than  ondansetron  .  
Formula:  C18H24N4°
Mol.Weight:  312.4
Mechanism  of  action:
Cytotoxic  drugs  and  radiotherapy  produce  nausea  and  vomiting 
by  causing  cellular  damage  →  release  of  5HT  from  intestinal  mucosa 
→  activation  of  vagal  afferent  gut  →  impulses  to  NTS  and  CTZ. 
Granisetron  blocks  emetogenic  impulses  both  at  their  peripheral  origin 
and  central  relay.  Its  main  effect  is  to  reduce  the  activity  of  the  vagus 
nerve.  It  does  not  block  dopamine  receptors.  The  weak  5HT4  blockade 
action  found  with  ondendetron  is  not  detected.
Pharmacokinetic  data:
Plasma  half  life  :  3-14  hrs.  But  the  anti  emetic  effect  persists 
long  after  the  drug  disappears  from  the  circulation,  suggesting  their 
continued  interaction  at  the  receptor  level23
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Volume  of  distribution: 3.07 L/kg
Peak  plasma  concentration :64 ng/min
  Bioavailability : 60%
 Protein  binding :  65  ±  9%
  Urinary  excretion :  16  ±  14%
 Faecal  excretion   :  38%
  Clearance               :  11  ±  9  ml/min/kg
Metabolism :
Its   metabolism  involves   N-Demethylation   amd  aromatic   ring 
oxidation  followed  by conjugation.
Therapeutics :
  Available  as  injection,  tablets  &  Syrup form
Dosage :
40mcg/kg.
To  be reduced  in  aged,  cirrhosis
No  change  in  renal  disease 
Uses:
Post   operative   nausea   &   vomiting,   chemotherapy   induced 
vomiting.
Side  Effects:  
Constipation,   headache,   light   headedness,   induce   minor   ECG 
changes  which  are  clinically  insignificant  
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REVIEW  OF  LITERATURE
1.  Fujii  Y,  Tanaka  H,  Toyookh 24 in  a  double  blind  study  examined 
the   useof   granisetron   Dexamethasone   combination   for   the 
prevention  of  post  operative  nausea  and  vomiting  (post  operative 
nausea  and  vomiting)  in  female  patients.  For  a  period  of  24  hrs, 
after  surgery,  a  complete  response  (emesis  free)  was  observed  in 
96% of  patients  who  received  granisetron  plus  dexamethasone  and 
82%  on  patients  who  received  granisetron  alone  and  50%  in 
placebo.  No  clinically  important  adverse  events  were  observed  in 
any  group.  Sub  analysis  based  on  the  data  shows  granisetron 
plus  dexamethasone  is  more  effective  than  granisetron  alone.
2.  Fujii  Y,  saitoh  y  et al25 did  a  randomized  double  blind  study 
examining   the   effectiveness   of   granisetron   40mcg/kg  , 
Dexamethasone   150mcgs/kg   and   granisetron   40mcg/kg   plus 
Dexamethasone  150mcg/kg  for  the  prevention  of  post  operative 
nausea  and  vomiting  in  children.  A  complete  response  (no  post 
operative  nausea  and  vomiting)  was  86%  in  granisetron  68%  with 
dexamethasone  and  98%  with  granisetron  plus  dexamethasone. 
They   conclude   that   prophylactic   therapy   with   combined 
granisetron  and  Dexamethasone  was  more  effective.
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3.  Fujii  Y,  Toyooka H,  Tanaka H 26 in    another  double  blind  study 
examined  the  efficacy  of  granisetron  (40mcg/kg)  Droperidol  (20 
mcg/kg)  and  metoclopramide  0.2  mg/kg  in  pt.  undergoing  middle 
ear   surgery   (The   conclusion   was   prophylactic   therapy   with 
granisetron  is  superior  in  the  prevention  of  post  operative  nausea 
and  vomiting  after  middle  ear  surgery.
4.  Fujii   Y,   et   al27 in   a   another   study   in   patients   undergoing 
Laparoscopic  cholecystectomy,  examined  the  effective  dose  of 
granisetron  for   the   prevention  of   post   operative  nausea  and 
vomiting.  The  incidence  of  post  operative  nausea  and  vomiting 
during  the  first  24hrs,  was  43%,  40%,  13%  and  13%  after 
administration  of  saline,  20  mcg/kg,  40mcg/kg  and  80mcg/kg  of 
granisetron  respectively.  They  concluded  that granisetron  40mcg/kg 
is  the  minimum  effective  dose  in  the  prevention  of  post  operative 
nausea  and  vomiting.
5.  Madan  R,  Bhatia  A  et  a28  in  a  double  blind  study  evaluated  the 
efficacy  and  safety  of  different  doses  of  prophylactic intravenous 
dexamethasone  for  post  operative  nausea  and  vomiting  and  they 
concluded  that  dexamethasone  0.25mg/kg  is  the  effective  dose  in 
preventing  post  operative  nausea  and  vomiting.
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6.  Lee   Y.   Lai  H y  et  al29 evaluated   the   anti   emetic   effect   of 
intravenous   dexamethasone   for   post   operative   nausea   and 
vomiting  in  women  with  and  without  H/o  motion  sickness  and 
they  concluded  that  prophylactic  administration  of  dexamethasone 
is  effective  in  reducing  post  operative  nausea  and  vomiting  in 
patients  with  and  without  H/o  of  motion  sickness.
7.  Fujii   Y,   Tanaka  H30 in  a  double  blind  study  compared  the 
efficacy  of  granisetron  alone  with  granisetron  plus  dexamethasone 
for   the   treatment   of   nausea   and   vomiting   after   major 
gynecological   surgery.   In   this   study,   they   concluded   that 
granisetron   plus   Dexamethasone   was   more   effective   than 
granisetron  alone  for  the  management  of  nausea  and  vomiting 
during  0-3hrs  after  major  gynecologic  surgery.
8.  Matsuoka  S,  okamotos  et al31  in  a  prospective  randomized  study 
compared   the   efficacy   and   toxicity   of   granisetron   and 
dexamethasone  with  those  of  granisetron  alone  for  anti  emetic 
control  in  patients  receiving  high  dose  chemotherapy  with/without 
irradiation.  They  concluded  that  granisetron  plus  Dexamethasone 
seems  superior  to  granisetron  alone  and  they  found  more  frequent 
side  effects,  but  none  of  the  events  were  serious.
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9.  Henz,  I  walder  B  et al 32 in  a  quantitative  systematic  review  from 
17  trials  found  that  the  best  prophylaxis currently  available    for 
post  operative  nausea  and  vomiting  is  achieved  by  combining 
dexamethasone  with  a  5HT3  receptor  antagonist.
10.  AL  pappar  et  al33 examined  the  effectiveness  of  preoperative 
dexamethasone  for  post  operative  nausea  and  vomiting  and  24 
hrs   recovery   in   children   undergoing   tonsillectomy.   They 
concluded,   that   dexamethasone   significantly   decreased   the 
incidence  of  post  operative  nausea  and  vomiting  during  the  24hrs 
after  discharge.
11.  Jhi-Joung   wang   et   al34 evaluated   the   timing   effect   of 
Dexamethasone  for  post  operative  nausea  and  vomiting  in  120 
patients   and   concluded   that,   the   prophylactic   intravenous 
administration  immediately  before  the  induction,  rather  than  at  the 
end  of  anesthesia  was  more  effective  in  preventing  post  operative 
nausea  and  vomiting.
12.  Al-shehri  A m  at  el35 in  a  double  blind  study  found  that inj. 
Dexamethasone   therapy   for   post   tonsillectomy   patients 
significantly  reduces  nausea  vomiting  and  pain  and  had  better  out 
come.
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13.   Fujii   Y,   Tanaka   H   et   al36 in   a   study   concluded    that 
Dexamethasone   8   mg  enhances   the   anti   emetic   efficacy   of 
granisetron   but   dose   not   potentiate  the   other   anti   emetics 
droperidol   and  metoclopramide  in  female   patients   undergoing 
major  gynecological  surgery.
14.  D’  Angelo  R  et  al37 in  a  pilot  study  explore  the  dose  –  response 
relationship  between  granisetron  administered  and  post  operative 
nausea  and  vomiting  symptoms.   They  concluded  a   trend  of 
improved  efficacy  with  dose  of  0.1,  0.2,  0.3  mg.  This  study  did 
not  identify  a  dose  response  relationship.
15.  Biswas  BN  et  al38 concluded  the  combination  (Granisetron  plus 
Dexamethasone)  increases  the  chance  of  complete  response  than 
granisetron   alone.   So   the   combination   might   be   considered 
clinically  relevant  in  a  high  risk  setting.
16.  De  wit  R.  et  a39  concluded  a  study  of  cross  over  to  granisetron 
after  failure  to  ondansetron  plus  dexamethasone  following  highly 
emetogenic  chemotherapy.  They  concluded  that  patients  who  have 
acute   protection   failure   on   one   5HT3   receptor   antagonist 
(ondansetron)   should   be   offered   to   cross   over   another 
(Granisetron).
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17.  Fujii  Y  at  al40 in  a  study  to  determine  the  minimum  effective 
dose  of  granisetron  for  the  prevention  of  post  operative  nausea 
and  vomiting  after  middle  ear  surgery.  They  conclude  Granisetron 
40   mcg/kg  appears   to   be   the   minimum  effective   dose   for 
preventing   post   operative   nausea   and   vomiting   in   women 
undergoing  middle  ear  surgery.
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MATERIALS  &  METHODS
  After  obtaining  approval  from  our  institutional  ethics  committee 
and  informed  consent,  90  Patients  of (ASA  Physical  status  1)  aged  15  - 
50  yrs.  with  body  weight  ranging  40  –  80kgs.  scheduled  for  elective 
ENT  surgeries  were  studied  at  the  Govt.  Stanley  Hospital,  Chennai.  
  Patient  with  cardiovascular,  respiratory,  renal  or  hepatic  diseases, 
pregnant,   lactating   (or)   menstruating   women   and   those   taking 
medications  which  would  affect  the  study,  those  who  had  a  H/o  of 
motion  sickness  and  or  previous  H/o  of  post  operative  nausea  and 
vomiting  were  excluded  from  the  study.
Premedication  -   Intramuscularly    Pentazocine   0.5  mg/kg, 
Glycopyrolate  0.2mg  half  an  hour before  surgery  for  all patients.
  
Patients  were  randomly  allocated  into  three  different  groups  (30 
in  each  group).  Patients  were given  in  a  randomized,  double -blind 
manner,  a  single  dose  of  normal  saline (placebo)  5ml, (or) Inj.Granisetron 
40mcg/kg,(GROUP  –II)   (or)  Inj.  Granisetron   40mcg/kg   with 
dexamethasone   8mg,  (GROUP –III)   intravenously.   Study   medications 
were  prepared  by  personnel  not  involved  in  the  study  in  identical  5  ml 
volume.  The  study  drugs  were  given  just  after  intravenous  cannulation , 
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before  Induction  of  anaesthesia.
  The  patients  were  fasted  for  eight  hours  before  surgery  and  on 
arrival   to   the   operating   theatre,   routine   monitoring   devices   were 
attached  and basal   HR,  BP,  ECG,  SPO2  were  observed  and  also 
observed   throughout  the  study  period. 
Anaesthesia  was  induced  with  Thiopentone  5 mg/kg  intravenously 
and succinylcholine  2mg/kg  intravenously  was  used  to  facilitate  tracheal 
intubation.
After  tracheal  intubation,  anaesthesia  was  maintained  with  66% 
nitrous   oxide,33%oxygen   with   0.5%    halathone   with   pancuronium 
bromide as    non  depolarising  muscle  relaxant.Ventilation  was  controlled 
mechanically  in  all  patients. 
  At  the  completion  of  surgery,  residual  neuro  muscular  blockade 
was   antagonized   with   intravenous   Glycopyrolate   0.01mg/kg   and 
neostigmine  0.04mg/kg.  the  trachea  was  extubated  when  the  patient  was 
awake.  Patients  were  shifted  to  the  recovery  room.
  They  were  asked  to inform   whether  they  had  nausea,  retching 
(or)  vomiting  during  the  first  24  hrs  and  was  recorded .  The  results 
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were  scored  in  a  manner  similar  to  Belville  et  al.
Grade  0  -  No  nausea  /retching  /  vomiting
Grade  1  -  Nausea/retching
Grade  2  -  Vomiting
Patients  were  assessed  for  nausea,   retching  and  vomiting  at 
1,2,4,12  &  24  hrs  post  operatively.  If  two  (or)  more  episodes  of  emesis 
occurred  Inj.  Metoclopramide  10mg  iv.  as  rescue  antiemetic  was  given.
  Results  were  statistically  analysed  with  t  test,  chi – square test 
They  were  also  enquired  about  adverse  effects  like  Headache, 
sedation,  abdominal  discomfort,  dizziness  etc  and  noted.
Group  wise  comparison  of  the  baseline  characteristics
TABLE – I
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Parameter
Group  I
(N  =  30)
Group  II
(N  =  30)
Group  III
(N  =  30)
P  value Inference
Age 
(Years) 29.2  ±  8.04 29.8  ±  9.7 29.1  ±  9.8 0.951 NS
Weight 
(Kg) 56.3  ±  6.9 59.3  ±  9.89 61.23  ± 10.26 0.1188 NS
Sex  (M:F) 14  ±  16 19  ±  15 16  ±  14 0.875 NS
P>0.05 indicates  statistically  not  significant  
                                                             TABLE – II
Parameter Group  I
(N  =  30)
Group  II
(N  =  30)
Group  III
(N  =  30)
P  
value
Inference
BP  Systolic 122.4  ± 7.9 119.5  ±9.38 121.6  ±10.12 0.4598 NS
BP  Diastolic 79  ±  7.12 77.4  ±  8.2 76.4  ±  6.8 0.396 NS
Surgical
Duration(mins)
96.7  ± 20.5 93.67  ±19.8 94.17  ±  18.9 0.817 NS
Pulse  Rate 82  ±  4.90 82.2  ±  6.8 79.8  ±  5.1 0.208 NS
P>0.05  indicates stastically   not  significant  .
Table  III  (a)
Incidence  of  Nausea  according  to  Groups
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Table  III  (b)
Comparison  of  Nausea P  Value Inference
Group  I  vs  Group  II <  0.001 S
Group  I  vs  Group  III <0.001 S
Group  II  vs  Group  III <0.02 S
Incidence  of  Retching  according  to  Groups  (0-24  hrs)
Table  -  IV
Retching
Group  I Group  II Group  III
No. % No. % No. %
Presence 24 80 5 16.7 1 3.3
Absence 6 20 25 83.3 29 96.7
Total 30 100 30 100 30 100
  P  value  <0.001
Incidence  of  Vomiting  according  to  Groups  (0-24  hrs)
Vomiting
Group  I Group  II Group  III
No. % No. % No. %
Presence 24 80 6 20 1 3.3
Absence 6 20 24 80 29 96.7
Total 30 100 30 100 30 100
  P  value  <0.001
Comparison  of  Vomiting
Comparison  of  Vomiting
P  Value Inference
Group  I  vs  Group  II <  0.001 S
Group  I  vs  Group  III <0.001 S
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Group  II  vs  Group  III <0.05 S
TABLE  V(b)
Distribution  of  Incidence  of  Vomiting  according  to  Groups
Vomiting 
episodes
Group  I Group  II Group  III
No. % No. % No. %
None 6 20 24 80 29 96.7
Single 6 20 3 10 1 3.3
Multiple 18 60 3 10 0
Total 30 100 30 100 30 100
Distribution  of  Patients  according  to  Nausea  score
Grade  0 Grade  1 Grade  2
No  Nausea/Vomiting
No  Rescues
Nausea/Retching Vomiting
TABLE V (c)
Grade Group  I Group  II Group  III
No. % No. % No. %
0 3 10 23 76.7 29 96.7
1 3 10 1 3.3 0
2 24 80 6 20 1 3.3
Total 30 100 30 100 30 100
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TABLE -VI
Group  wise  distribution  of  side  effects
Side 
effects
Group  I Group  II Group  III P  Value
No. % No. % No. %
Headache 3 10 3 10 2 6.7 0.87
Sedation 1 3.3 1 3.3 2 6.7 0.76
Abdominal 
discomfort
1 3.3 1
3.3
1 3.3 1
Dizziness 2 6.7 1 6.7 2 6.7 0.80
RESULTS
  This  was  a  randomised,  double  blind  placebo  controlled  study 
conducted  at  Govt.  Stanley  Hospital.  CHENNAI  AFTER  OBTAINING 
INFORMED  CONSENT  FROM  ALL  THE  90  PATIENTS  SUBJECTED 
TO  STUDY.  They  were   grouped  into  three   groups   and  received 
placebo,  Granisetron  40  mcg’s/Kg  and  Granisetron  40  mcg’/kg  with 
dexamethasone  8  mg.
Age,   weight,   sex   distribution,     systolic   &  Diastolic   Blood 
pressure,  Heart  rate  were  not  significantly  different  in  these  groups  as 
can  be  seen  in  table  I. and  table II.
Surgical  duration :
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      Group  I     Group  II    Group  III
  96  +  7  ±  20.53  93.67  ±  19.87  94.17  ±  18.94
Incidence  &  Severity  of  Nausea  
Table  III  (a)  shows  incidence  of  nausea  0-  24  hrs.  As  shown  in 
Table  III  (a)  90%  of  the  patients  in  the    group I  and  23%  in  the 
group II had  nausea  while  it  fell  to  4%  in  group III.
Comparison  of  Nausea  between  Groups  
Table  III  b  compares  the  incidence  of  nausea  between  each 
groups  individually  ie.  Group  I  with  Group  II  and  Group  II  with 
Group  III.  etc.
  From  the  above  mentioned  table  one  we  see that ,  the  incidence 
of  nausea  is  reduced  significantly  both  in Group II  and  Group  III 
.Among   these  two,  the  grade  0  was  in  96%  of  patients  in  Group  III 
(P<0.05).
Incidence  of  Retching
Similarly  the  incidence  of  retching  was  compared  in  all  the  three 
groups.  Group  I  shows  an  incidence  of  80%  and  group  II  shows  17% 
and  group  III  shows  only  4%.
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Incidence  of  Vomiting
As  seen  in  table  V  (a)   the  Incidence  of  vomiting  in  group I  is 
80%  and  in   group II it  is  20%  and  in   group III  is  only  4%.
When  number of  episodes  are compared  as shown  in  table  V  (b), 
it was  seen  that  in  group  I  it is  60%, in group II  it is10%  and none  in 
group  III  have multiple  episodes  and  the  need  for  rescue  antiemetic.
Comparison  of  Vomiting  between  Groups  
Table  V  (b)  statistically  analyses  the  differences  in  the  incidence 
of  vomiting  when  compared  with  group I , group II  shows  statistically 
significant  but  Group III  is  more  effective.
Table  V(c),  shows  a  complete  response  (no  post  operative  nausea 
and  vomiting)  occurred  96%  in    group III  and  77%  in  group II   and 
10%  in  group I .  Thus  a  complete  response  was  significantly  more 
common  in  the  patients  who  had  received  the  drugs  Granisetron  and 
Dexamethasone.
  Table  VI  shows  the  Incidence  of  some  side  effects  which  were 
not  statistically  significantly  among  the  groups.
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                                           DISCUSSION
Post   Operative   Nausea   and   Vomiting   is   distressing   and 
sometimes,  the  patients  dread  it  more  than  post  operative  pain.  There 
are  various  factors  that  predispose  a  Patient  to  post  operative  nausea 
and  vomiting.  It  is  more  frequent  in  women,  in  non  smokers,  in  Pts 
with  a  past  History  of  motion  sickness,  morning  sickness  or  post 
operative  nausea  and  vomiting  and  with  perioperative  use  of  opioid.
The  frequency  of  nausea  and  vomiting  following  middle  ear 
surgery  can  be  as  high  as  62%-80%.  If  the  prophylactic  anti emetic  is 
not  given  in  our  study  the  incidence  is  little  bit  higher  of  about  90% 
in  control  group.
Prophylactic   administration   of  scopolamine,   prochlorperazine, 
droperidol,  5HT3  antagonists  and  combination  of  anti  emetics  have  been 
advocated  for  post  operative  nausea  and  vomiting  in  middle  ear  surgery 
and  in  ENT  surgeries  in  various  studies.  Ondansetron  has    been  less 
effective  in  preventing  post  operative  nausea  and  vomiting  in  middle 
ear  surgery  patients.41
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Granisetron  alone  (or)  in  combination  with  dexamethasone  has 
been  shown  to  be  highly  effective  in  patients  undergoing  middle  ear 
surgery  as  concluded  by  Fujii  et  al  in  various  studies.24,25,13
  
In  high  risk  population,  the  current  mode  of  preventing  post 
operative  nausea  and  vomiting  is  by  multimodal  therapy  and  commonly 
used  combinations  are  5HT3  receptor  antagonist  &  Dexamethasone.,13
  So  in our  present  study  we  tried  to  compare  the  efficacy  of 
Granisetron   40   mcg/kg    with   Granisetron   40   mcg/kg   plus 
Dexamethasone 8mg  and   found  statistically  significant  decrease  in  the 
incidence  of  nausea  and  vomiting  between    group  I , group  II  and 
Group  III.
 All  factors  which   predisposed  to  increase  post  operative  nausea 
and  vomiting   like   age,obesity,   gender,   durations   type   of   surgery, 
anaesthetic  technique  are  equally  distributed  among  the  groups  and 
hence  the  difference  in  the  incidence  of  complete  response  between 
groups  and  the  requirement  of  rescue  anti  emetics  between  groups  can 
be  attributed  to  the  difference  in  the  anti  emetics  tested.
  The  possible  mechanism  of  Dexamethasone  action  might  be 
to  decrease  the  level  of  prostaglandins  in  the  central  nervous  system. 
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They  regulate  neurotransmitter  concentrations,  receptor  densities  signal 
transduction  and  neuronal  configuration. 19,13
  As   concluded   in   many   studies   the   granisetron   plus 
Dexamethasone  significantly   reduces  the  post   operative  nausea  and 
vomiting  when  given  prophylactically.24,25,38It  is  usually  recommended 
that   an   anti   emetic   be   given   prophylactically   before   surgery   or 
chemotherapy  to  improve  the  efficacy  of  the  drug.  Hence,  the  study 
agents  were  administered  intravenously  before  the  commencement  of 
surgery.  The  dose  of  granisetron  used  in  this  study  was  based  on  the 
previous  studies  by  Fujii  et  al.27  They  have  suggested  that  40  mcg/kg 
was  the  minimum  effective  dose  for  prevention  of  post  operative  nausea 
and  vomiting  following  surgery.  The  dose  of  dexamethasone  used  (8 
mg)28  was  based  on  the  studies  previously  shown  to  decrease  emesis 
when  added  as  an  anti  emetic  regimen.  In  the  present  study,  therefore, 
the  same  dose  of  dexamethasone  was  added  to  granisetron.
The  precise  mechanism  by  which  dexamethasone  increase  the 
effectiveness   of   granisetron   is   not   known.   Granisetron   produces 
antiemesis  by  blocking  5HT3  receptors.   Dexamethasone  may  inhibit 
stimulation   of   5HT3  receptors   and   may  also   potentiate   the   other 
pharmacological  receptors32,28
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Ali  sz  et  al  studied  the  effects  of  pre-op  fluid12 on  the  post 
operative  nausea  and  vomiting  and  found  a  considerable  decrease  in  the 
incidence  of  post  operative  nausea  and  vomiting.  
Apfel  cc  et  al  concluded  that  volatile  anaesthetics10 were  the 
leading  cause  of  early  post  operative  vomiting.  The  pro emetic  effect 
was  larger  than  other  risk  factor.  In  patients  who  are  at  high  risk  for  
post  operative  nausea  and  vomiting,  it  would  therefore  be  better  to 
avoid  inhalation  anaesthesia.
Adeno -tonsillectomy  is  also  associated  with  a  high  post  operative 
nausea  and  vomiting  rate  (36-76%)  patel  R.  Rouley.  This  is  thought  to 
be  due  to  the  irritant  effects  of  blood  on  oesophago  gastric  chemo 
receptors,  irritation  of  trigeminal  afferents  during  surgery.
In  our  study  the  incidence  of  post  operative  nausea  and  vomiting 
is  high  among  female  patients.
Obesity  increases  the  incidence  of  vomiting,  in  our  study  patients 
who  weighed  more  than  60  kg  had  increased  incidence.  Gigilo  at  al 41 
in   their   study   to   prevent   nausea   and   vomiting   following   cancer 
chemotherapy  concluded  that  both  ondansetron  and  granisetron  have 
similar  anti  emetic  efficacy  but  dose  of  granisetron  is  much  less  than 
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ondansetron  iv.  Moreover  ondansetron  has  a  shorter  half-life  of  3  hrs, 
whereas  granisetron  has  a  half  life  of  8-9  hrs,  for  for  which  it  is  more 
effective  in  preventing  nausea  and  vomiting.  Granisetron  is  also  a  more 
selective  5HT3  receptor  antagonist  than  ondansetron44,42
In  our  study  the  need  for  rescue  antiemetic  in  group I  is  60%, 
groupII  is  10%  where  as  in  group  III  is  nil.
The  safety  of  intravenous  and  oral  granisetron  has  been  evaluated 
in  more  than  7,000  patients  in  clinical  trial,  which  have  shown  the 
drug  to  be  well  tolerated,  with  mild  and  transient  side  effects.  There 
have   been   no   reports   of   extrapyramidal   side   effects   with   either 
intravenous  or  oral  granisetron  for  the  prevention  and  treatment  of 
chemotherapy-induced  emesis  and  post  operative  nausea  and  vomiting. 
In  our  study  also  patients  tolerate  the  drug  well  with  few  side  effects  .
In  our  study  patients  receiving  placebo  had  stayed  in  the  hospital 
more  than  patients  receiving  Granisetron  with  dexamethasone.  
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CONCLUSION
Antiemetic   prophylactic   should  be   definitely   included  in   the 
anaesthetic  management  of  patients  with  risk  post  operative  nausea  and 
vomiting  undergoing  general  anaesthesia.
 Granisetron  is  effective  in  preventing  post  operative  nausea  and 
vomiting  in  majority  patients.
 Granisetron   plus   Dexamethasone   combination   prophylaxis   is 
highly  effective  in  controlling  postoperative  nausea  and  vomiting  with 
few  side  effects.
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A - Tonsillectomy 
B - Myringo plasty
C - Tympano plasty
D - Stapedectomy
E - Septoplasty
F - FESS
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PROFORMA
SI.No.  ...................  Name:...................................  Age/Sex:.................................
IP.No.:..............................  Wt.  :...................................  ASA  :............................
Diagnosis:.................................... Surgery:..........................................................
Study  drug  given  before  induction  of  Anaesthesia
Duration  of  Surgery:  ………………………  
   (in  mins )
                                                                
                                  Pulse Rate                Blood Pressure
Pre  OP :
Intra  OP :
Post  OP :
Time  in  hours                  1       2       4       12        24
Incidence  of  Nausea
  Retching
  
 Vomiting
(no  of  episodes )
Rescue  antiemetic
Side  effects   (if  any )  :
 
